查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056410

腸溶軟膠囊市場報告：按類型、應用、分銷管道和地區分類（2026-2034 年）

Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球腸溶軟膠囊市場規模達28億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到38億美元，2026年至2034年的複合年成長率為3.32% 。成長要素包括全球老年人口的成長、慢性病和營養缺乏症盛行率的上升，以及人們對營養補充品的接受度不斷提高。

腸溶軟膠囊市場趨勢：

慢性病盛行率增加

腸溶軟膠囊市場的成長主要受糖尿病、心血管疾病和胃腸道疾病等慢性病盛行率上升的推動。根據美國疾病管制與預防中心 (CDC) 估計，美國約有 1.29 億人患有至少一種主要慢性病，包括心臟病、癌症、糖尿病、肥胖和高血壓。此外，美國十大死因中有五種是可預防和可治療的慢性病，​​或與這些疾病密切相關。過去 20 年來，慢性病的盛行率持續上升，預計這一趨勢還會持續。腸溶軟膠囊有利於治療需要長期照護的疾病，因為它們能夠將藥物持續且精準地輸送到標靶。這些膠囊在腸道而非胃部釋放藥物，確保藥物在最有效的部位被吸收。這種標靶給藥方式是慢性病管理的理想選擇，因為它能夠增強療效並減少副作用。隨著人口老化、久坐的生活方式和飲食習慣的改變加劇了全球慢性病的負擔，對腸溶軟膠囊和其他先進藥物輸送技術的需求預計將進一步成長。

人們越來越偏好營養補充劑

推動腸溶軟膠囊市場規模成長的另一個因素是消費者對膳食補充劑日益成長的興趣。根據美國國家醫學圖書館統計，過去十年全球營養保健品和膳食補充品市場穩定成長，2019年市場規模達3,530億美元。該領域的研究也日益增多，PubMed資料庫中收錄了超過7萬篇與功能性食品和膳食補充劑相關的文章。此外，始於2019年11月的由嚴重急性呼吸道症候群冠狀病毒2 (SARS-CoV-2) 引起的新冠肺炎感染疾病，進一步推動了2020年初膳食補充劑和功能性食品的銷售。腸溶軟膠囊廣泛應用於營養保健品產業，用於輸送維生素、礦物質和其他膳食補充劑。這些膠囊具有許多優勢，包括提高營養吸收率和生物利用度、保護敏感成分免受胃酸侵蝕，以及提升消費者遵守用藥。隨著人們對健康益處的認知不斷提高，越來越多的人將營養補充品納入日常生活中。這種趨勢在老年人和注重健康的消費者中尤其明顯，他們希望透過補充劑來預防或治療健康問題。

人口老化的進程

推動腸溶軟膠囊市場價值成長的另一個主要因素是老年人口的成長。根據聯合國預測，全球65歲及以上人口數量預計將增加一倍以上，從2021年的7.61億增加到2050年的16億。 80歲及以上人口的成長速度更快。老年人通常有獨特的醫療需求，例如需要管理多種慢性疾病，並且需要易於吞嚥、對消化系統溫和的藥物。腸溶軟膠囊恰好滿足這些需求，為服用處方藥和營養補充劑提供了一種便捷高效的方式。由於老年人更容易出現消化器官系統問題，因此這些膠囊的腸溶包衣尤其重要。此外，隨著預期壽命的延長和出生率的下降，全球老年人口正在不斷成長。腸溶軟膠囊有助於提高患者的用藥依從性和治療效果，因此，隨著人口結構的變化，預計其需求量將會增加。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球腸溶軟膠囊市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 明膠膠囊
  • 非明膠軟膠囊

第7章 市場區隔：依應用領域分類

  • 保健品
  • 製藥

第8章 市場區隔：依分銷通路分類

  • 超級市場和大賣場
  • 藥局和藥局
  • 網路商店

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Aenova Group GmbH
    • BASF SE
    • Catalent, Inc.
    • Colorcon Inc.
    • Fuji Capsule Co., Ltd.
    • Lonza Group AG
    • Now Health Group, Inc.
    • ProCaps Group
    • Super Spectrim
    • Thermo Fisher Scientific, Inc.
Product Code: SR112026A4232

The global enteric softgel capsules market size reached USD 2.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 3.32% during 2026-2034. The market is primarily driven by the growing global geriatric population, the rising prevalence of chronic medical disorders and nutrient-deficient diseases, and the growing acceptance of nutritional and dietary supplements.

Enteric Softgel Capsules Market Trends:

Growing prevalence of chronic diseases

The enteric softgel capsule market growth is significantly driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and gastrointestinal disorders. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Moreover, over the past two decades prevalence has increased steadily, and this trend is expected to continue. Enteric softgel capsules offer a continuous and targeted release of medication, which is beneficial for treating illnesses that often require long-term treatment. By releasing its contents in the intestines instead of the stomach, these capsules make sure the medication is absorbed where it works best. This targeted administration is a desirable alternative for managing chronic diseases since it can enhance therapeutic outcomes and lessen side effects. With aging populations, sedentary lifestyles, and changing dietary habits contributing to the global burden of chronic diseases, enteric softgel capsules and other sophisticated drug delivery technologies are likely to become more and more in demand.

Increasing preference toward nutritional supplements

Another factor propelling the enteric softgel capsule market revenue is the growing inclination of consumers toward dietary supplements. As per the National Library of Medicine, the global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth $353 Billion in 2019. Research in the field has also grown, with over 70,000 published articles available in PubMed relating to nutraceuticals or dietary supplements respectively. Besides, the occurrence of the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) starting in November 2019 led to an even greater increase in sales of dietary supplements and nutraceuticals in early 2020. The nutraceutical sector uses enteric softgel capsules extensively to provide vitamins, minerals, and other nutritional supplements. These capsules have a number of benefits, including as increased nutrient absorption and bioavailability, shielding delicate components from stomach acids, and improving customer convenience and compliance. More people are including nutritional supplements in their regular routines as awareness of their health advantages develops. This trend is especially prominent among older populations and health-conscious consumers who want to use supplements to prevent or treat medical issues.

Rising geriatric population

Another major aspect increasing the enteric softgel capsule market value is the growing geriatric population. According to the United Nations (UN), the global population aged 65 years or older is expected to be more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 years or older is growing at an even faster rate. Elderly people frequently have particular healthcare demands, such as managing several chronic illnesses and requiring easy-to-swallow, gastrointestinal-friendly drugs. These criteria are met by enteric softgel capsules, which provide a practical and efficient method of delivering prescription drugs and dietary supplements. These capsules' enteric coating is especially helpful as digestive problems are more common in the elderly population. Additionally, as life expectancy rises and birth rates fall, the world's senior population is expanding. Enteric softgel capsules, which can improve medication adherence and treatment outcomes, are among the healthcare items that are predicted to see an increase in demand as a result of this demographic transition.

Enteric Softgel Capsules Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on type, application and distribution channel.

Breakup by Type:

  • Gelatin Capsules
  • Non-Gelatin Softgel Capsules

Gelatin capsules accounts for the majority of the market share

As per enteric capsules market forecast, gelatin capsules are widely preferred due to their exceptional biocompatibility and absorption. Derived from animal collagen, gelatin is an easily absorbed and digested natural protein by the human body. It is also safe for a variety of consumers including those with sensitive stomachs or dietary restrictions due to its biocompatibility. Gelatin capsules are also renowned for having a high bioavailability, or the ability of the active substances to be effectively absorbed into the bloodstream. Hence, there is an escalating demand for gelatin for manufacturing softgel capsules. As per National Liabrary of Medicine, the market for gelatin in 2020 reached USD 3.18 Billion and is further expected to reach USD 4.08 Billion by 2024 as forecasted in the same report.

Breakup by Application:

  • Health Supplements
  • Pharmaceuticals

Health supplements hold the largest share of the industry

The market is dominated by health supplements primarily due to the increasing awareness of the value of preserving general health and wellbeing. According to the Research Gate, 53.7 % of the participants of the survey took dietary supplements upon the doctor's advice, 28.5 % took them with their own decision, and 15.9 % took them after friend advice; 87.4 % of the participants bought supplements in the pharmacy. As the wellness sector grows, more people are taking an active role in their health and looking for supplements that help boost immunity, deliver vital nutrients, and stave against chronic illnesses. As enteric softgel capsules can shield delicate components from stomach acids, improving absorption and bioavailability in the intestines, they are an appealing delivery option for these nutrients.

Breakup by Distribution Channel:

  • Supermarkets and Hypermarkets
  • Pharmacy and Drug Stores
  • Online Stores

Pharmacy and drug stores represent the leading market segment

Pharmacy and drug stores hold a significant market share in the market. These widely dispersed and consumer-friendly retail locations offer a practical point of sale for prescription drugs and nutritional supplements. Pharmacists can offer expert guidance, customers frequently choose to purchase health-related products from pharmacies, guaranteeing that their decisions are well-informed. As per the report published by Mckinsey, retail chains are the largest and most prevalent of the four pharmacy types, representing a third of stores and about a third of prescription revenues in 2021. On a per-store basis, retail chains dispense approximately 138,000 prescriptions annually about 50 percent more than grocers, the next largest prescription dispensers per retail location in US.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest enteric softgel capsules market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for enteric softgel capsules.

An important driver creating a favorable enteric softgel capsules market outlook in North America is the increasing prevalence of chronic disorders. As per National Library of Medicine, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050.Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Owing mostly to aging populations and lifestyle choices, conditions like diabetes, cardiovascular illnesses, and gastrointestinal ailments are prevalent in the area. Enteric softgel capsules provide targeted and sustained release of medications, which is beneficial for patients with chronic conditions who often need long-term treatment. These capsules are a recommended option for managing chronic diseases since they enhance therapeutic outcomes and minimize adverse effects. The substantial market share of North America is mostly attributed to the rising prevalence of chronic illnesses, which in turn drives demand for efficient and practical drug delivery methods.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major enteric softgel capsules companies in the industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.
  • As per enteric softgel capsules market research report, key players are establishing strategic alliances and partnerships to strengthen their position. They are also innovating through collaboration with academic institutions, research centers, and other pharmaceutical firms. These partnerships frequently result in the exchange of technology and information as well as the co-development of new goods, all of which greatly strengthen a business's competitive advantage. Increasing production capacity is yet another important tactic used by top competitors in the enteric softgel capsule industry. Businesses can boost production capacity and boost operational efficiency by investing in new production facilities or renovating existing ones. Moreover, companies are entering emerging markets, where the demand for advanced pharmaceutical products is rising, which is providing significant growth opportunities.

Key Questions Answered in This Report

  • 1.What was the size of the global enteric softgel capsules market in 2025?
  • 2.What is the expected growth rate of the global enteric softgel capsules market during 2026-2034?
  • 3.What has been the impact of COVID-19 on the global enteric softgel capsules market?
  • 4.What are the key factors driving the global enteric softgel capsules market?
  • 5.What is the breakup of the global enteric softgel capsules market based on the type?
  • 6.What is the breakup of the global enteric softgel capsules market based on the application?
  • 7.What is the breakup of the global enteric softgel capsules market based on the distribution channel?
  • 8.What are the key regions in the global enteric softgel capsules market?
  • 9.Who are the key players/companies in the global enteric softgel capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Softgel Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsules
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Gelatin Softgel Capsules
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Health Supplements
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Supermarkets and Hypermarkets
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacy and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aenova Group GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BASF SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Catalent, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Colorcon Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fuji Capsule Co., Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Now Health Group, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 ProCaps Group
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Super Spectrim
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Softgel Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Softgel Capsules Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Enteric Softgel Capsules Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Enteric Softgel Capsules Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Enteric Softgel Capsules Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Enteric Softgel Capsules Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: Enteric Softgel Capsules Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Enteric Softgel Capsules (Gelatin Capsules) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Enteric Softgel Capsules (Gelatin Capsules) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Enteric Softgel Capsules (Health Supplements) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Enteric Softgel Capsules (Health Supplements) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Enteric Softgel Capsules (Pharmaceuticals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Enteric Softgel Capsules (Pharmaceuticals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Enteric Softgel Capsules (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Enteric Softgel Capsules (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: United States: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: United States: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Canada: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Canada: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia-Pacific: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia-Pacific: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: China: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: China: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Japan: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: India: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: India: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: South Korea: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: South Korea: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Australia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Australia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Indonesia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Indonesia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Germany: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Germany: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: France: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: France: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: United Kingdom: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: United Kingdom: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Italy: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Italy: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Spain: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Spain: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Russia: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Russia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Brazil: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Brazil: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Mexico: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Mexico: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: Enteric Softgel Capsules Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: Enteric Softgel Capsules Market: Breakup by Country (in %), 2025
  • Figure 70: Middle East and Africa: Enteric Softgel Capsules Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: Enteric Softgel Capsules Industry: SWOT Analysis
  • Figure 72: Global: Enteric Softgel Capsules Industry: Value Chain Analysis
  • Figure 73: Global: Enteric Softgel Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Softgel Capsules Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Enteric Softgel Capsules Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Enteric Softgel Capsules Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Enteric Softgel Capsules Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: Enteric Softgel Capsules Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Enteric Softgel Capsules Market: Competitive Structure
  • Table 7: Global: Enteric Softgel Capsules Market: Key Players